Browsing Wolfson Institute of Preventive Medicine by Author "Crnogorac-Jurcevic, T"
Now showing items 1-15 of 15
-
A 3-Dimensional Coculture Model to Visualize and Monitor Interaction Between Pancreatic Cancer and Islet β Cells
Kumar, S; Jach, D; Macfarlane, W; Crnogorac-Jurcevic, T (2021) -
Abstract 5077: Proteomics analysis of extracellular vesicles from pancreatic cancer cells and cancer associated fibroblasts
Pan, S; Lai, LA; Simeone, DM; Dawson, DW; Yan, Y; Crnogorac-Jurcevic, T; Chen, R; Brentnall, TA (American Association for Cancer Research (AACR), 2022-06-15) -
A combination of urinary biomarker panel and PancRISK score for earlier detection of pancreatic cancer
Debernardi, S; Jach, D; Brezgyte, G; Blyuss, O; Crnogorac-Jurcevic, T (Elsevier, 2020-11) -
Complement system genetic variability shapes pancreatic cancer risk
Langtry, A; Rabadan, R; Alonso, L; Lawlor, R; Carrato, A; Hidalgo, M; Iglesias, M; Molero, X; Löhr, M; MICHALSKI, C (Elsevier, 2023-11) -
EARLY DETECTION OF PANCREATIC ADENOCARCINOMA IN ‘AT-RISK’ POPULATIONS USING A BIOMARKER PANEL IN URINE (UROPANC)
Crnogorac-Jurcevic, T; Debernardi, S; Jach, D; Brezgyte, G; Ney, A; Pereira, SP; Greenhalf, W; Wilson, P; Duffy, S; Blyuss, O (Elsevier, 2020-12) -
From development to cancer - an ever-increasing role of AGR2
Jach, D; Cheng, Y; Prica, F; Dumartin, L; Crnogorac-Jurcevic, T (2021) -
Gallbladder disease and pancreatic cancer risk: a multicentric case-control European study
Rosato, V; Gomez-Rubio, P; Molina-Montes, E; Marquez, M; Lohr, M; O'Rorke, M; Michalski, CW; Molero, X; Farre, A; Perea, J (2021) -
Leukocyte-DNA methylome explains a large proportion of the risk variability of pancreatic cancer
De Maturana, EL; Alonso, L; Carrato, A; Iglesias, M; Molero, X; Hidalgo, M; Perea, J; Barberá, V; Farré, A; Tardón, A (Elsevier, 2021-07) -
Nutraceuticals as Supportive Therapeutic Agents in Diabetes and Pancreatic Ductal Adenocarcinoma: A Systematic Review
Mikolaskova, I; Crnogorac-Jurcevic, T; Smolkova, B; Hunakova, L (2023) -
Pentraxin 3 is a stromally-derived biomarker for detection of pancreatic ductal adenocarcinoma
Goulart, MR; Watt, J; Siddiqui, I; Lawlor, RT; Imrali, A; Hughes, C; Saad, A; ChinAleong, J; Hurt, C; Cox, C (2021) -
The protective effect of atopic diseases against pancreatic cancer is not driven by Th2-biomarkers
He, J; Alhamwe, BA; Sabroso, S; Carrato, A; Hidalgo, M; Richard, XM; Coma, MI; Perea, J; Farré, A; Tardón, A (Elsevier, 2023-11) -
Proteomes of Extracellular Vesicles From Pancreatic Cancer Cells and Cancer-Associated Fibroblasts
Pan, S; Lai, LA; Simeone, DMM; Dawson, DWW; Yan, Y; Crnogorac-Jurcevic, T; Chen, R; Brentnall, TA (2022) -
S100PBP is regulated by mutated KRAS and plays a tumour suppressor role in pancreatic cancer
Srivastava, K; Lines, KE; Jach, D; Crnogorac-Jurcevic, T (2023) -
S100PBP is regulated by mutated KRAS and plays a tumour suppressor role in pancreatic cancer
Srivastava, K; Lines, K; Jach, D; Crnogorac-Jurcevic, T (Elsevier, 2020-11) -
Urine biomarkers enable pancreatic cancer detection up to 2 years before diagnosis
Debernardi, S; Blyuss, O; Rycyk, D; Srivastava, K; Jeon, CY; Cai, H; Cai, Q; Shu, X-O; Crnogorac-Jurcevic, T (2023)